• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625315003
Device Problem High Readings (2459)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/08/2021
Event Type  malfunction  
Manufacturer Narrative
The test strips were requested for investigation and have not been received at this time.If the product is returned in the future, a follow-up report will be submitted.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling: "coaguchek method uses human recombinant thromboplastin.Therefore, the comparability to tests using other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastin types.However, those higher differences between thromboplastins of different (rabbit, bovine) origin are not an issue specific for coaguchek assays.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared with several other (rabbit, bovine) laboratory methods." occupation is lay user/patient.
 
Event Description
There was an allegation of a questionable inr result for one patient tested with coaguchek xs meter with serial number (b)(4) compared to an unknown laboratory method.The result from the meter at 7:30 was 3.4 inr.The laboratory result at 8:00 was 2.6 inr.The patient's interval for testing is once to twice a week.The patient's therapeutic range is 1.8 - 2.8 inr.
 
Manufacturer Narrative
The returned test strips were measured on reference meters with a high level control sample.Testing results (qc range: 2.5 - 3.1 inr): qc 1: 2.9 inr.Qc 2: 2.8 inr.Qc 3: 2.8 inr.All inr values were within the specified target ranges, confirming the functionality of the complained coaguchek test strips.No error messages occurred.Medwatch fields d9 and h3 have been updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS PT TEST
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key12545612
MDR Text Key273755545
Report Number1823260-2021-02841
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Type of Report Initial,Followup
Report Date 10/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/31/2021
Device Catalogue Number04625315003
Device Lot Number43492812
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/23/2021
Initial Date Manufacturer Received 09/08/2021
Initial Date FDA Received09/29/2021
Supplement Dates Manufacturer Received10/04/2021
Supplement Dates FDA Received10/26/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
APYDAN EXTENT; BRIVIIAKT; DESLORATADIN,; ELTHRYOXIN; FYCOMPA; PHENPFIBRAT; PHENPROGAMMA 3; TARGRETIN (CHEMO); APYDAN EXTENT; BRIVIIAKT; DESLORATADIN,; ELTHRYOXIN; FYCOMPA; PHENPFIBRAT; PHENPROGAMMA 3; TARGRETIN (CHEMO)
Patient Age58 YR
Patient Weight78
-
-